{
    "nctId": "NCT03696056",
    "briefTitle": "Improving Brain Function After Breast Cancer Study",
    "officialTitle": "Improving Cognition in Breast Cancer Survivors Using Meditation: A Pilot Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer Survivors",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 36,
    "primaryOutcomeMeasure": "Verbal learning and memory performance-Hopkins Verbal Learning Test Immediate and Delayed Recall",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Individuals with a history of non-inflammatory breast cancer (stages I-IV):\n* Received chemotherapy as part of their treatment\n* Completed chemotherapy treatment 3 months to 10 years prior to study enrollment\n* Individuals who have report cognitive deficits\n\nExclusion Criteria:\n\n* Breast cancer survivors with a history of metastases to the brain\n* A physician diagnosis of: dementia, a learning disability, unmanaged major depression, psychosis, schizophrenia, bipolar, traumatic brain injury, cancer of the central nervous system, diabetes, arthritis\n* Taking oral steroids within 30 days of enrolling\n* A regular meditation practice (greater than 1 time per week)\n* Currently taking immune modifying medications",
    "sex": "ALL",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}